Off-Patent Industry Must Become ‘Focal Point’ For Health Systems Post-COVID
Medicines For Europe And IGBA Set Out Policy Priorities At Athens Conference
• By David Wallace
Generics and biosimilars must be a “focal point” for health systems • Source: Alamy 
